ANGELA LESLIE: Open Payments
NPI 1114171501 · KATY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 85 payments from 18 companies in 2025. Trend: 2023 $971 · 2024 $1,412 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 18 | $298 |
| Novo Nordisk Inc | 17 | $259 |
| ABBVIE INC. | 16 | $232 |
| Dexcom, Inc. | 5 | $137 |
| AstraZeneca Pharmaceuticals LP | 4 | $135 |
| Lilly USA, LLC | 4 | $69 |
| Azurity Pharmaceuticals, Inc. | 3 | $63 |
| PFIZER INC. | 3 | $61 |
| Amgen Inc. | 4 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
Products named: FREESTYLE LIBRE 3, VRAYLAR, Dexcom G6 Transmitter, Ozempic, Wegovy, AIRSUPRA, MOUNJARO, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
